Immunotech Biopharm Ltd (HKG:6978)
Hong Kong · Delayed Price · Currency is HKD 0.3500
-0.0100 (-2.78%)
Nov 3, 2026, 3:59 PM HKT
Immunotech Biopharm Market Cap
Immunotech Biopharm has a market cap or net worth of 216.13 million as of November 3, 2026. It is the 34,416th most valuable company in the world and the 1,848th biggest in Hong Kong. Its market cap has decreased by 86.58% in one year.
Market Cap
216.13M
Enterprise Value
605.29M
Revenue
n/a
Global Rank
Country Rank
#1,848 Hong Kong
PE Ratio
n/a
ChartMarket Cap Chart
Since July 10, 2020, Immunotech Biopharm's market cap has decreased from 7.74B to 216.13M, a decrease of -97.21%. That is a compound annual growth rate of -43.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 216.13M | -88.05% |
| Dec 31, 2025 | 1.81B | 52.87% |
| Dec 31, 2024 | 1.18B | -54.00% |
| Dec 29, 2023 | 2.57B | 7.99% |
| Dec 30, 2022 | 2.38B | -72.51% |
| Dec 31, 2021 | 8.67B | 50.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wuhan YZY Biopharma | 775.40M |
| Brii Biosciences | 707.42M |
| Kintor Pharmaceutical | 666.64M |
| 3D Medicines | 641.85M |
| Sirnaomics | 449.75M |
| Uni-Bio Science Group | 394.10M |
| B&K Corporation | 384.74M |
| Transcenta Holding | 313.81M |